Industry News
Mesoblast stem cell trial shows reduced heart failure risk
Mesoblast's stem cell treatment for cardiovascular conditions is the first to have shown efficacy in treating the main causes of congestive heart failure. [ + ]
Doug Hilton receives accolade for grassroots outreach
WEHI head, Professor Doug Hilton, has received the 2011 Research Australia Leadership and Innovation Award in part for his agitation over the rumoured cuts to health and medical research. [ + ]
Starpharma raises $32m to fund VivaGel trial
Starpharma Holdings (ASX:SPL) has raised $32 million in a placement, and will seek a further $3 million in a SPP, to help fund clinical trials and new product development. [ + ]
Biotech and pharma driving HPLC market to US$4.1bn
The global HPLC systems and accessories market is forecast to reach US$4.1bn by 2017, according to a new report by Global Industry Analysts.
[ + ]Comment invited on R&D Tax Incentive Discussion Paper
AusIndustry has released a Discussion Paper on the R&D Tax Incentive in an effort to engage with a wide range of audiences to encourage an innovation culture and enable the development of strong guidance material for the new R&D Tax Incentive. [ + ]
Psivida plummets after FDA knockback
Share price drops by over 50% as FDA demands two more clinical trials for Psivida's flagship treatment, Iluvien, before it's approved for sale. [ + ]
Phosphagenics raises $3 million in oversubscribed SPP
Victoria-based Phospagenics (ASX:POH) has raised $3 million in a heavily oversubscribed share purchasing plan to fund the development of its targeted drug delivery products. [ + ]
Moles, eye colour and the genetics of skin cancer
A new study has identified that a gene variation associated with a greater number of moles and non-blue eye colour is linked to an increased risk of melanoma. [ + ]
Tackling breast cancer requires national coordination: report
A new report by the Economist Intelligence Unit says "fragmentation" of research, funding and treatment of breast cancer is hampering Australia's response to the disease. [ + ]
Broadvector acquires CSIRO prostate cancer vaccine IP
Broadvector has completed acquisition of IP from CSIRO for early-stage prostate cancer therapy and prostate cancer vaccine, with CSIRO becoming a major shareholder in the company. [ + ]
Mesoblast posts successful results from diabetes stem cell trial
A pre-clinical animal trial of Mesoblast's (ASX:MSB) stem cell treatment for Type 2 diabetes has shown positive results, with phase II trial planned for 2012. [ + ]
Sunshine Heart sees positive results in heart pump trial
Feasibility trial shows Sunshine Heart's (ASX:SHC) C-Pulse heart pump significantly improved heart function, setting the stage for more thorough testing in 2012. [ + ]
AusBiotech announces formation of the AusMedtech Health Economics Expert Panel
A new health economics panel has been launched to advise on key issues affecting medical devices companies regarding the assessment and reimbursement of medical devices diagnostics in Australia. [ + ]
Malaria vaccine wins Gates Foundation grant
A carbohydrate-based malaria vaccine developed by Australian researchers has won a US$1 million grant from the Bill & Melinda Gates Foundation. [ + ]
